Clinical Trial Update: Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

View source ↗

Summary

A clinical trial update on the Parkinson's Progression Markers Initiative using the PET tracer [18F] AV-133 and DaTscan imaging to study progression markers in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• DaTscan (ioflupane)
• [18F] AV-133 (AV-133)

Snippet

Sponsor: Michael J. Fox Foundation for Parkinson's Research | Conditions: Parkinson Disease | Status: ACTIVE_NOT_RECRUITING